Description
The Practicing Oncologists Working Group is pleased to present a new series of Spotlight articles featuring highlights from the ESMO 2021 Congress.
Watch the presentations and make sure you keep up to date on the key practice changing outcomes from this year's annual meeting.
Produced by the Practising Oncologists Working Group
Featured abstracts
VP4_2021 - EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs investigator’s choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma
Presenter: Krishnansu S Tewari - Session: Virtual Plenary Debate
Abstract, slides and webcast
LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase III KEYNOTE-826 study
Presenter: Nicoletta Colombo - Session: Presidential symposium 1
Abstract, slides and webcast
LBA33 - Maintenance olaparib rechallenge in patients (pts) with ovarian carcinoma (OC) previously treated with a PARP inhibitor (PARPi): Phase IIIb OReO/ENGOT Ov-38 trial
Presenter: Eric Pujade-Lauraine - Session: Proffered Paper session - Gynaecological cancers
Abstract, slides and webcast
